GlakoLens

Based in Turkey, GlakoLens is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

GlakoLens develops a non-invasive biosensor platform integrated into a contact lens for continuous 24-hour monitoring of intraocular pressure (IOP), enabling earlier and more accurate glaucoma diagnosis and personalized treatment options.